Santa Flavia, Italy

Antonio Palumbo Piccionello


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antonio Palumbo Piccionello: Innovator in Antibiotic Compounds

Introduction

Antonio Palumbo Piccionello is a notable inventor based in Santa Flavia, Italy. He has made significant contributions to the field of antibiotic research, particularly through his innovative work on oxazolidinone compounds. With a total of 2 patents, his inventions focus on combating gram-positive pathogens, which are crucial in the fight against antibiotic resistance.

Latest Patents

Antonio's latest patents include the development of 1,2,4-Oxadiazol compounds that exhibit activity against gram-positive pathogens. The first patent describes new oxazolidinone compounds of general formula (I) that possess antibiotic activity, even against multiresistant bacterial strains. The second patent also relates to novel oxazolidinone compounds of the same general formula, emphasizing their effectiveness against multiresistant bacterial strains.

Career Highlights

Throughout his career, Antonio has worked with esteemed institutions such as the Istituto Euro Mediterraneo di Scienza e Tecnologia and the Università degli Studi di Milano-Bicocca. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Antonio has collaborated with notable colleagues, including Rosario Musumeci and Clementina Elvezia Anna Cocuzza. These partnerships have enriched his research and fostered innovation in the field of antibiotic development.

Conclusion

Antonio Palumbo Piccionello stands out as a dedicated inventor whose work on antibiotic compounds addresses critical health challenges. His contributions are vital in the ongoing battle against antibiotic resistance, showcasing the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…